Delivery Order SPE2DB25D2204-SPE2DB25FTGYX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $12,222.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation, indicating the contract was competed openly among...
- The Defense Logistics Agency awarded a $5,249.48 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of RINVOQ ER 15 MG tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a performance completion date of August 19, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $22,157.82 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a Delivery Order valued at $24,066.84 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $8,372.73 to AmerisourceBergen Drug Corp on August 19, 2025, for RINVOQ ER 15 mg tablets (30-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating the contractor's ability to...
- The Defense Logistics Agency awarded a $28,684.94 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order, which is set to be completed by September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, valued at $12,728.50. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded contract and is set to be completed by August 15, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $6,223.32 and is structured as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $15,876.35 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed price contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,223.30. This non-competitive delivery order is scheduled for ultimate completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGYXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $41,153.31 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the opportunity was open to all qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The broader IDC vehicle enables the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.2k | 9/3/25 |